Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anuvia Plant Nutrients was an agricultural biotechnology company that manufactured high-efficiency, sustainable bio-based fertilizers for the agriculture, turf, and lawncare industries. The company utilized a proprietary technology to convert organic waste materials, such as food and livestock waste, into high-performance plant nutrient products that improved soil health and reduced environmental impact. Their flagship products, including SymTRX and GreenTRX, were designed to increase crop yields while sequestering carbon and reducing nutrient leaching by up to 50%. Despite raising over $300 million in venture capital and establishing strategic partnerships with industry leaders like Mosaic and Novozymes, Anuvia suspended operations and began liquidating its assets in May 2023. The company's closure was attributed to a challenging capital environment and the high costs associated with scaling its manufacturing infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anuvia Plant Nutrients.